ASTHMA - ALLERGIC

 

ASTHMA - ALLERGIC

 

DEFINITION:

An inflammatory disorder of the respiratory mucosa initiated by an IgE-mediated hypersensitivity.

EPIDEMIOLOGY:

  • incidence: ?
  • age of onset:
    • usually greater than 4 years of age
  • risk factors:
    • family history of atopy
  • associations:
    • an allergic triad
      • 50-80% of patients with atopic dermatitis will go on to develop asthma and/or allergic rhinitis

PATHOGENESIS:

1. Allergy

  • 1. Background

    • allergy is the manifestation of a hypersensitive reaction to the presentation of an allergen due to the propensity of the affected individual to develop a sustained IgE response - the distinguishing feature of the allergic individual is the propensity to develop a sustained IgE response - there are several types of allergies based upon where the hypersensitive reaction occurs:
  • Surface-Allergy

    • Nasal Mucosa-Allergic Rhinitis
    • Skin-Hives (Urticaria), Atopic Dermatitis
    • Respiratory Tract-Allergic Asthma
    • Systemic-Anaphylaxis
  • 2. Allergens

    • allergens are compounds capable of inducing human IgE antibody formation ("sensitization")
  • 3. IgE

    • IgE is a Homocytotropic Antibody: an antibody capable of interacting with target cells such that there cells release mediators on contact with specific antigens
    • the IgE receptor consists of an externally located alpha chain that binds the IgE and is noncovalently associated with a beta chain and two gamma chains
    • there are two categories of IgE receptors dependent upon the type of cells targetted and the type of mediators re-leased from these cells:
  • 1. Type 1

    • target cells - mast cells, basophils
    • affinity - high affinity fro IgE
    • mediators - histamine, ECF-A, leukotrienes, bradykinins, prostaglandins, PAF, anaphylatoxins

    2. Type 2

    • target cells - lymphocytes, platelets, eosino-phils, monocytes-macrophages
    • affinity - low affinity for IgE
    • mediators - chemotaxic factors, IgE binding factors (T cells), mitogens (B cells), inflammatory mediators

    2. Allergic Asthma

  • 1. Background

    • an allergy specific to the respiratory mucosa in suscep-tibe individuals
  • 2. Allergens

  • 1. Pollens
    • grass (freshly-cut), trees, weeds
  • 2. Fungi
    • spores, mycelial fragments
  • 3. Mammals
    • cats, dogs, rodents, horses
    • react with the saliva and urine
  • 4. Antropods
    • dust mite feces, blood worms
  • 5. Foods
    • seafood, shellfish, peanuts, kiwi, diary products
  • 6. Others
    • feathers
  • 3. IgE

    • within the respiratory mucosa Type 1 and Type 2 homocyto-tropic antibody responses occur
  • CLINICAL FEATURES:

    1. Respiratory Manifestations

    1. When the appropriate allergen is encountered:

    • cough
    • wheeze
    • dyspnea
    • associated symptoms
      • allergic rhinitis - runny nose
      • atopic dermatitis - dry skin

    2. Timing

  • 1. Seasonal
    • symptoms wax and wane with the seasons
    • pollens most likely allergen
  • 2. Perennial
    • symptoms occur year round
    • fungi, mammals, antropods most likely allergens
  • 3. Intermittent
    • occasional episodes with no symptoms in between
  • INVESTIGATIONS:

    1. Serum

    • elevated IgE
    • eosinophilia

    2. Allergy Tests

    • In Vivo - skin tests - immediate, delayed, patch skin test
    • In Vitro - Immunoassays -RAST, MAST, ELISA

    MANAGEMENT:

  • I. APPROACH

  • 1. Diagnosis + Education
  • 2. Goals of Therapy
  • 3. Avoidance of Allergen
  • 4. Medications
  • 1. Beta-2 Agonists
  • 2. Non-Steroidal Antiinflammatory Drugs
    • Intal
    • Ketotifen
    • Tilade
  • 3. Steroids
    • Inhaled
    • Oral
  • 1. Diagnosis + Education

  • 1. What is Asthma
    • diagnosis based upon history, physical, investigations, etc
    • 2 components - inflammation, bronchospasm
  • 2. Identification of Allergens
    • which allergens trigger the asthma
  • 3. Management Plans For:
    • interval asthma - period between exacerbations
    • acute exacerbation
    • when asthma is out of control
    • also remember that controlling allergic rhinitis (+/-sinusitis) will help to control the allergic asthma
  •  

    2. Goals of Therapy

    • absence of symptoms upon exposure to allergen
    • normal exercise tolerance
    • normal spirometry and peak flows
    • infrequent or no bronchodilator use

     

    3. Avoidance of Allergens

  • 1. Pollens and Molds
    • shut windows and use window air conditioners during warm days or days when the pollen count is high
    • dehumidification of home
    • clean with Clorox (1-10% solution - 1 tbs in a pail of water with detergent [Tide])
  • 2. Mammals
    • weekly baths of pets
    • remove pets from house or getting rid of pet is the best method of reducing the level of animal dander
  • 3. Antropods (Dust Mites)
  • 1. Vacuum and Dust Effectively
    • central vacuum most effective
    • upright vacuum least effective
    • damp mop or dust all hard surfaces - floors, furniture
    • vacuum mattress and pillow at least once per week
  • 2. Maintain Optimal Humidity
    • keep indoor humidity about 50% in the summer and 35% in the winter
    • use an air conditioner in the summers
    • can moniter humidity with a hygrometer
  • 3. Bedroom
  • 1. Mattress

    • use a water bed or cover mattress with a dust mite impermeable barrier
    • encase and vacuum box springs
    • wash mattress protectors weekly in hot water

    2. Pillow

    • avoid feather or foam pillows
    • use pillows of synthetic fibre

    3. Sheets

    • wash bedding and curtains weekly
      • temperature must be > 130 degrees F to kill mites
      • may use 4 oz. of Australian tea tree oil as well (sold in health food stores)

    4. Blankets

    • unnapped, washable, synthetic or cotten
    • avoid wool blankets or duvets

    5. Furnishings

    • remove all rugs, carpeting, drapes, dust ruffles
    • frequently clean bedroom
    • avoid or store dust-collecting toys outside bedroom
    • keep bedroom door shut

    4. Medications

  • 1. Acute
    • in anticipation of encountering a known allergen, take Intal 1 nebule or 4 puffs qid one day prior to exposure
  • 2. Chronic
    • see Management of "Asthma - Chronic"
  •  

     

     

     

     

    Pediatric Database - ASTHMA - ALLERGIC

    Pediatric Organization - Pedbase [at] Gmail.com